MN Services Vermogensbeheer’s NovoCure NVCR Stock Holding History

MN Services Vermogensbeheer’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-45,900	Closed	-$1.91M	–	451
2023 Q2	$1.91M	Hold	45,900	–	–	0.02%	447
2023 Q1	$2.76M	Hold	45,900	–	–	0.03%	394
2022 Q4	$3.37M	Sell	45,900 -5,900	-11%	-$444K	0.04%	383
2022 Q3	$3.94M	Sell	51,800 -4,100	-7%	-$320K	0.04%	379
2022 Q2	$3.88M	Sell	55,900 -9,000	-14%	-$678K	0.04%	404
2022 Q1	$5.38M	Sell	64,900 -3,400	-5%	-$250K	0.04%	359
2021 Q4	$5.13M	Hold	68,300	–	–	0.03%	370
2021 Q3	$7.93M	Buy	68,300 +700	+1%	+$106K	0.05%	357
2021 Q2	$12.6M	Buy	+67,600	New	+$13.2M	0.1%	238

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

MN Services Vermogensbeheer's NVCR Position: Q3 2023 in Review

MN Services Vermogensbeheer sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 45,900 shares — an estimated $1.91M sold.

MN Services Vermogensbeheer first reported a position in NVCR in Q2 2021 and held it in 9 quarters. The position peaked at $12.6M in Q2 2021. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

MN Services Vermogensbeheer reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
MN Services Vermogensbeheer sold 45,900 NovoCure shares in Q3 2023, an estimated $1.91M.
MN Services Vermogensbeheer first reported a position in NovoCure in Q2 2021 and held it in 9 quarters.
MN Services Vermogensbeheer's NovoCure position peaked at $12.6M in Q2 2021.
226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on MN Services Vermogensbeheer's 13F filing for Q3 2023, filed 25 Oct 2023.